Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
SeizureEpilepsyCerebral Malaria
Interventions
DRUG

LEVETIRACETAM

liquid, 40 mg/kg loading dose and 30mg/kg every 12 hours via nasogastric tube for 3 days--this is standard dose. If primary outcome is not reached, dose escalation to 150, 225, and 300% standard, as needed, will be conducted.

Trial Locations (1)

3

Queen Elizabeth Central Hospital, Blantyre

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Rochester

OTHER

NCT01660672 - Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria | Biotech Hunter | Biotech Hunter